Clinical Features and Molecular Markers on Diffuse Midline Gliomas With H3K27M Mutations: A 43 Cases Retrospective Cohort Study
PurposeDiffuse midline gliomas (DMG) with H3K27M mutations have been identified as a rare distinctive entity with unique genetic features, varied molecular alterations, and poor prognosis. The current study aimed to evaluate the clinical characteristics and profile of molecular markers on patients w...
Main Authors: | Yuan Wang, Lan-lan Feng, Pei-gang Ji, Jing-hui Liu, Shao-chun Guo, Yu-long Zhai, Eric W. Sankey, Yue Wang, Yan-rong Xue, Na Wang, Miao Lou, Meng Xu, Min Chao, Guo-Dong Gao, Yan Qu, Li Gong, Liang Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.602553/full |
Similar Items
-
Mosaic Pattern of H3 K27M-Mutant Protein Expression in a Diffuse Midline Glioma—A Diagnostic Dilemma for the Pathologist
by: Deepti Narasimhaiah, et al.
Published: (2021-05-01) -
Diffuse midline glioma-H3K27M mutant. A novel entity with a defining and specific IHC marker
by: Prachi Agarwal, et al.
Published: (2021-01-01) -
A longitudinally extensive H3 K27M-mutant diffuse midline
glioma in an elderly patient clinically mimicking central nervous
system inflammation: a case report
by: Kristof Babarczy, et al.
Published: (2021-01-01) -
A case of diffuse midline glioma with histone H3 K27M mutation mimicking long segmental myelitis
by: Hsin-Pin Lin, et al.
Published: (2021-03-01) -
Pediatric Diffuse Midline Gliomas H3 K27M-Mutant and Non-Histone Mutant Midline High-Grade Gliomas in Neurofibromatosis Type 1 in Comparison With Non-Syndromic Children: A Single-Center Pilot Study
by: Federica Garibotto, et al.
Published: (2020-06-01)